Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers Squibb's much-touted rival deucravacitinib ...
US exits Paris Agreement after submitting Nationally Determined Contributions. In mid-December, the Biden Administration announced it submitted the ...